|
시장보고서
상품코드
1964467
체외진단용 면역진단 원료 시장 규모, 점유율, 성장 분석 : 제품 유형별, 용도별, 지역별 - 업계 예측(2026-2033년)IVD Immunodiagnostic Raw Material Market Size, Share, and Growth Analysis, By Product Type (Core Reaction System, Signal System), By Application (Therapeutic Drug Monitoring, Oncology), By Region - Industry Forecast 2026-2033 |
||||||
세계의 체외진단용 면역진단 원료 시장 규모는 2024년에 132억 3,000만 달러로 평가되었으며, 2025년 144억 6,000만 달러에서 2033년까지 294억 5,000만 달러로 성장할 전망입니다. 예측 기간(2026-2033년) 동안 CAGR은 9.3%로 예측됩니다.
IVD 면역진단용 원료 시장은 주로 임상, 공중보건, 연구 환경에서 사용되는 면역 측정에 필수적인 신뢰할 수 있고 확장 가능한 시약에 대한 수요 증가에 힘입어 성장하고 있습니다. 공급업체는 감염, 종양학 바이오마커, 자가면역질환 검사에 필수적인 항체, 재조합 항원, 효소, 소모품 등 다양한 필수 성분을 제공하는데 주력하고 있습니다. 단클론항체 생산 및 바이오 제조 기술의 발전으로 시장은 크게 발전했고, 측면 흐름법 및 실험실 기반 검사의 비용 효율성이 향상되었습니다. 또한, 설계 및 제조 공정의 기술 혁신은 병원과 진료소에서 선별검사 프로그램의 보급을 촉진하고 있습니다. 또한, AI는 검사 자동화 및 예측 모델링을 통해 품질 관리를 강화하여 시약의 품질과 검사 성능의 일관성을 보장합니다.
세계 IVD 면역진단용 원료 시장 활성화 요인
세계 IVD 면역진단용 원료 시장은 임상 검사실, 병원, 분산형 검사 환경 등 다양한 의료 현장에서 면역 측정법의 활용이 증가하면서 시장을 견인하고 있습니다. 이러한 추세에 따라 항체, 항원, 접합체, 특수 완충액 등 고품질 원료에 대한 안정적인 수요가 발생하고 있습니다. 분석 감도와 재현성을 향상시키려는 제조업체는 신뢰할 수 있는 재료 공급원과 표준화된 제조 공정을 필요로 합니다. 그 결과, 공급업체들은 생산능력 증대, 품질 관리 강화, 맞춤형 제형에 대한 투자에 대한 압박을 받고 있습니다. 이러한 지속적인 조달 활동은 공급업체의 안정적인 수익을 지원하고, 혁신을 촉진하며, 새로운 분석법을 쉽게 도입할 수 있도록 돕습니다. 궁극적으로 탄탄한 공급망과 업계의 협력적 파트너십을 통해 시장의 성장을 촉진할 수 있을 것입니다.
세계 IVD 면역진단용 원료 시장의 억제요인
세계 IVD 면역진단용 원료 시장은 원료를 둘러싼 복잡하고 끊임없이 변화하는 규제 요건으로 인해 심각한 제약에 직면해 있습니다. 이러한 엄격한 규제는 개발 기간의 장기화와 공급업체 및 제조업체의 컴플라이언스 비용 증가를 통해 시장 성장을 저해할 수 있습니다. 철저한 문서화, 배치 추적성, 필수 인증에 대한 요구는 검증, 품질 관리, 규제 대응을 위한 막대한 자원 배분을 필요로 하며, 특히 시장 진입 및 확장을 시도하는 중소 규모의 공급업체에게 불리한 상황을 초래합니다. 또한, 지역마다 다른 기준을 준수하고 지속적인 시판 후 조사를 실시해야 하기 때문에 업무의 유연성이 떨어지고, 제품 출시가 지연될 수 있습니다. 그 결과, 제조업체들은 혁신적인 신규 진입 기업보다 기존 공급업체를 우선시하는 경향이 강해 시장 역학을 저해하는 요인으로 작용하고 있습니다.
세계 IVD 면역진단용 원료 시장 동향
전 세계 IVD 면역진단용 원료 시장에서는 현장 검사 솔루션으로 크게 전환하고 있으며, 제조업체들은 분산형 검사 환경을 위해 특별히 설계된 원료에 초점을 맞추고 있습니다. 이러한 추세는 상온에서 안정한 제형, 단순화된 시약 혼합물, 카트리지 기반 시스템과 호환되는 구성요소에 대한 수요 증가로 특징지어집니다. 공급업체는 원활한 워크플로우 통합과 일관된 제품 품질을 보장하기 위해 생산능력 강화 및 장비 제조업체와의 공동 개발에 힘쓰고 있습니다. 또한, 소형화 및 다중화에 중점을 두면서 저용량 및 고특이성 검사가 가능한 재료의 필요성이 높아지고 있습니다. 이를 통해 공급망 전반의 연계 강화가 촉진되고, 다양화되는 PO(Point of Care) 용도의 진화하는 니즈에 대응하기 위해 신뢰성, 맞춤화, 물류 유연성이 강조되고 있습니다.
자주 묻는 질문
목차
소개
조사 방법
주요 요약
시장 역학과 전망
주요 시장 인사이트
세계의 체외진단용 면역진단 원료 시장 규모 : 제품 유형별 & CAGR(2026-2033년)
세계의 체외진단용 면역진단 원료 시장 규모 : 용도별 & CAGR(2026-2033년)
세계의 체외진단용 면역진단 원료 시장 규모 & CAGR(2026-2033년)
경쟁 정보
주요 기업 개요
결론과 제안
KSM 26.03.23Global Ivd Immunodiagnostic Raw Material Market size was valued at USD 13.23 Billion in 2024 and is poised to grow from USD 14.46 Billion in 2025 to USD 29.45 Billion by 2033, growing at a CAGR of 9.3% during the forecast period (2026-2033).
The IVD immunodiagnostic raw material market is primarily driven by an increasing need for dependable and scalable reagents essential for immunoassays utilized in clinical, public health, and research environments. Suppliers are focused on delivering a range of necessary components such as antibodies, recombinant antigens, enzymes, and consumables, crucial for testing infectious diseases, oncology biomarkers, and autoimmune disorders. The market has evolved significantly through advancements in monoclonal antibody production and biomanufacturing, enhancing the affordability of lateral flow and lab-based assays. Furthermore, technological innovations in design and manufacturing processes are fostering broader adoption of screening programs in hospitals and clinics. Additionally, AI is augmenting quality control by automating inspections and predictive modeling, thereby ensuring robust reagent quality and assay performance consistency.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Ivd Immunodiagnostic Raw Material market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Ivd Immunodiagnostic Raw Material Market Segments Analysis
Global ivd immunodiagnostic raw material market is segmented by product type, application and region. Based on product type, the market is segmented into Core Reaction System, Signal System, Carrier and Reaction Environment. Based on application, the market is segmented into Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Test, Autoimmune Disease and Other. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Ivd Immunodiagnostic Raw Material Market
The global IVD immunodiagnostic raw material market is driven by the rising use of immunoassays in various healthcare settings, including clinical laboratories, hospitals, and decentralized testing environments. This trend has led to a consistent demand for high-quality raw materials such as antibodies, antigens, conjugates, and specialized buffers. Manufacturers, aiming to enhance assay sensitivity and reproducibility, seek dependable sources of materials and standardized manufacturing processes. Consequently, suppliers are compelled to boost their production capacity, enhance quality control measures, and invest in custom formulations. This ongoing procurement supports stable supplier revenues, encourages innovation, and facilitates the introduction of new assays, ultimately fostering market growth through robust supply chains and collaborative industry partnerships.
Restraints in the Global Ivd Immunodiagnostic Raw Material Market
The Global IVD Immunodiagnostic Raw Material market faces significant constraints due to complex and ever-changing regulatory requirements surrounding raw materials. These stringent regulations can hinder market growth by lengthening development timelines and increasing compliance costs for both suppliers and manufacturers. The demands for thorough documentation, batch traceability, and necessary certifications necessitate the allocation of substantial resources toward validation, quality management, and regulatory affairs, which can particularly disadvantage smaller suppliers trying to enter or expand within the market. Furthermore, the need to adhere to varying regional standards and to conduct continuous postmarket surveillance diminishes operational flexibility, delays product launches, and frequently prompts manufacturers to favor established suppliers over innovative newcomers, ultimately stifling market dynamism.
Market Trends of the Global Ivd Immunodiagnostic Raw Material Market
The Global IVD Immunodiagnostic Raw Material market is experiencing a significant shift toward point-of-care testing solutions, prompting manufacturers to focus on raw materials specifically designed for decentralized testing environments. This trend is characterized by a rising demand for room-temperature-stable formulations, simplified reagent mixes, and components compatible with cartridge-based systems. Suppliers are responding by enhancing their production capabilities and engaging in collaborative development with device manufacturers to ensure seamless workflow integration and consistent product quality. Additionally, the emphasis on miniaturization and multiplexing is driving the need for materials that enable low-volume, high-specificity assays, thereby fostering greater collaboration across supply chains and emphasizing reliability, customization, and logistical flexibility to meet the evolving needs of diverse point-of-care applications.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
- Value Chain Analysis
Global IVD Immunodiagnostic Raw Material Market Size by Product Type & CAGR (2026-2033)
- Market Overview
- Core Reaction System
- Signal System
- Carrier
- Reaction Environment
Global IVD Immunodiagnostic Raw Material Market Size by Application & CAGR (2026-2033)
- Market Overview
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease Test
- Autoimmune Disease
- Other
Global IVD Immunodiagnostic Raw Material Market Size & CAGR (2026-2033)
- North America (Product Type, Application)
- US
- Canada
- Europe (Product Type, Application)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Product Type, Application)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Product Type, Application)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Product Type, Application)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Siemens Healthineers
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Roche Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Rad Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Beckman Coulter
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Quidel Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Agilent Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Meridian Bioscience
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hologic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ortho Clinical Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Genentech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PerkinElmer
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Becton, Dickinson and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Enzo Biochem
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- DiaSorin
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Fujifilm Wako Pure Chemical Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- R-Biopharm AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Scienion AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- The Binding Site Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
